跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMIKACIN SULFATE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMIKACIN SULFATE INJECTION
Authorized
STANDARD
AMIKACIN SULFATE INJECTION
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a4ce2a60edc34eb3
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
a4ce2a60edc34eb3
Drug Approval Canada Name
AMIKACIN SULFATE INJECTION
Product Name
AMIKACIN SULFATE INJECTION
Status
Marketed
Status Date
2023-04-28
Original Market Date
2023-04-28
Din
02525909
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Prescription
Ahfs
08:12.02
Atc Original
J01GB06 AMIKACIN
Atc Name
j 01 gb 06
Aig Number
0111922001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
AMIKACIN (AMIKACIN SULFATE)
250 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a4ce2a60edc34eb3
Type
Standard
Back to Health Canada Approvals